The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under ...

Investigators assessed the prevalence of adverse pregnancy outcomes among women with spondyloarthritis vs a matched ...

HealthDay News — With the end of federal health insurance subsidies, President Donald Trump has floated a new plan aimed at ...

Prioritizing nonpharmacologic strategies, enhancing staff training, and distinguishing Delirium Superimposed on Dementia (DSD) are vital to improving outcomes for hospitalized patients with Alzheimer ...

HealthDay News — Between 2019 and 2024, there was a decline in skilled nursing facility (SNF) capacity, with a decrease in ...

Early childhood is a key period for immune maturation, yet evidence linking early animal exposures with the development of ...

HealthDay News — The count and rate of emergency department (ED) visits for alcohol-specific diagnoses increased from ...

Zycubo is a copper replacement therapy administered via subcutaneous injection to bypass impaired GI absorption in patients with Menkes disease.

FDA grants Breakthrough Therapy designation to ianalumab for Sjögren disease after the monoclonal antibody showed significant disease improvement.

Many professionals report awareness, but few actively prescribe the self-administered injectable contraceptive DMPA.

Federal funding for mental health and addiction treatment programs will continue after the Trump administration abruptly reversed a plan to end nearly $2 billio ...